Current Edition

Clinical Trial Liability – Navigating the Legal, Regulatory and Insurance Landscape
Volume 10 Issue 6

Clinical Trial Liability – Navigating the Legal, Regulatory and Insurance Landscape

Clinical trials can have unforeseen consequences even where protocol and best practice are followed. This article by Katie Chandler of Taylor Wessing looks at the ris...
Continue Reading →
The Need to Streamline Adverse Event Reporting for Clinical Trials
Volume 10 Issue 6

The Need to Streamline Adverse Event Reporting for Clinical Trials

Given limitations in study size, duration and increasingly earlier approvals, pharmaceutical companies must garner as much relevant, accurate and timely data as possi...
Continue Reading →
Globalisation and the Importance of End-to-end Translation Management
Volume 10 Issue 6

Globalisation and the Importance of End-to-end Translation Management

Most manufacturers are now global in their outlook as it has become easier than ever for pharmaceutical and medical device companies to market their products all over...
Continue Reading →
Evolution of Diagnostic Criteria for Multiple Sclerosis: Implications for Clinical Trials
Volume 10 Issue 6

Evolution of Diagnostic Criteria for Multiple Sclerosis: Implications for Clinical Trials

Clinically establishing a diagnosis of multiple sclerosis (MS) typically does not represent a difficult diagnostic challenge, notwithstanding the tendency to recall o...
Continue Reading →
Artificial Intelligence in Clinical Trials and Medicine: Is This a Reality?
Volume 10 Issue 6

Artificial Intelligence in Clinical Trials and Medicine: Is This a Reality?

2018 and beyond seems to be the era of predictive analytics, and data is leading the way. Is the fourth age a systems revolution rather than a product revolution? Thi...
Continue Reading →
Usability Testing: Ensuring User-friendly Data Collection in Clinical Trials
Volume 10 Issue 6

Usability Testing: Ensuring User-friendly Data Collection in Clinical Trials

Collecting accurate and representative data from patients is vital, whether it’s in the context of clinical data collection that will determine a treatment plan, or a...
Continue Reading →
The Promise of Artificial Intelligence (AI) and Machine Learning in Clinical Drug Development: Impact in the Field of Cardiac Safety
Volume 10 Issue 6

The Promise of Artificial Intelligence (AI) and Machine Learning in Clinical Drug Development: Impact in the Field of Cardiac Safety

With recent advances in technology, computer science and informatics, new techniques in medicine became available, and existing tools and measurements were drasticall...
Continue Reading →
The Digital World of Clinical Research
Volume 10 Issue 6

The Digital World of Clinical Research

Shiyan Caan of SQN Health examines the tools and services which provide the clinical trial market with the ability to adapt to a changing environment. With an abundan...
Continue Reading →